OncoPrecision Corporation Market Research Report
Company Overview
- Name: OncoPrecision Corporation
- Mission: Leveraging single-cell high-throughput biology and AI/ML to dramatically increase the success of cancer therapy.
- Founded: 2020
- Founders: No information is available.
- Key People:
- Tarek Ali Zaki: CEO
- Dr. Gastón Soria: Co-Founder & Chief Scientific Officer
- Daniela Soledad Arroyo: Head of Myeloma Team
- Ignacio Corvalán: Hematologist
- Headquarters: 180 Varick St, 6th Floor, New York, NY, 10014
- Number of Employees: 11-50
- Revenue: No information is available.
- Known For: Specializing in oncology, using innovative technology to advance cancer therapy outcomes.
Products
- Product Offerings: No specific product details are available.
- High-level Description: OncoPrecision specializes in biotechnology research, particularly focusing on oncology through advanced technologies like single-cell high-throughput biology and AI/ML.
- Key Features: No information is available.
Recent Developments
- Recent Developments:
- Participated in The Leukemia & Lymphoma Society's "Light the Night" event to raise funds and awareness for blood cancer patients.
- Celebrated its 4th-year anniversary reflecting on past achievements.
- Awarded a Golden Ticket by Biolabs@NYULangone, covering a year’s rent for one of its Wet Lab Scientists.
- New Products Launched: No information is available.
- New Features Added: No information is available.
- New Partnerships: Collaborated with Biolabs@NYULangone and New York City Economic Development Corporation, as recognized by the Golden Ticket award.
OncoPrecision continues to position itself as a leader in biotechnology research by utilizing cutting-edge technologies to tackle cancer treatment challenges. Despite limited public data on specific product offerings, its active involvement in industry events and recognition by significant organizations highlights its growing influence and innovation in the field.
